These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 9616228)
1. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. Murohara T; Asahara T; Silver M; Bauters C; Masuda H; Kalka C; Kearney M; Chen D; Symes JF; Fishman MC; Huang PL; Isner JM J Clin Invest; 1998 Jun; 101(11):2567-78. PubMed ID: 9616228 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of ischemia-induced angiogenesis by eNOS overexpression. Amano K; Matsubara H; Iba O; Okigaki M; Fujiyama S; Imada T; Kojima H; Nozawa Y; Kawashima S; Yokoyama M; Iwasaka T Hypertension; 2003 Jan; 41(1):156-62. PubMed ID: 12511546 [TBL] [Abstract][Full Text] [Related]
3. Mouse model of angiogenesis. Couffinhal T; Silver M; Zheng LP; Kearney M; Witzenbichler B; Isner JM Am J Pathol; 1998 Jun; 152(6):1667-79. PubMed ID: 9626071 [TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Tamarat R; Silvestre JS; Kubis N; Benessiano J; Duriez M; deGasparo M; Henrion D; Levy BI Hypertension; 2002 Mar; 39(3):830-5. PubMed ID: 11897773 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799 [TBL] [Abstract][Full Text] [Related]
6. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Silvestre JS; Bergaya S; Tamarat R; Duriez M; Boulanger CM; Levy BI Circ Res; 2001 Oct; 89(8):678-83. PubMed ID: 11597990 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906 [TBL] [Abstract][Full Text] [Related]
8. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286 [TBL] [Abstract][Full Text] [Related]
9. Age-dependent impairment of angiogenesis. Rivard A; Fabre JE; Silver M; Chen D; Murohara T; Kearney M; Magner M; Asahara T; Isner JM Circulation; 1999 Jan 5-12; 99(1):111-20. PubMed ID: 9884387 [TBL] [Abstract][Full Text] [Related]
10. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240 [TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Silvestre JS; Tamarat R; Senbonmatsu T; Icchiki T; Ebrahimian T; Iglarz M; Besnard S; Duriez M; Inagami T; Lévy BI Circ Res; 2002 May; 90(10):1072-9. PubMed ID: 12039796 [TBL] [Abstract][Full Text] [Related]
17. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation. Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569 [TBL] [Abstract][Full Text] [Related]
18. Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model. Takahashi N; Shibata R; Ouchi N; Sugimoto M; Murohara T; Komori K J Vasc Surg; 2015 Feb; 61(2):489-96. PubMed ID: 24993950 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia. Shyu KG; Chang H; Isner JM Life Sci; 2003 Jun; 73(5):563-79. PubMed ID: 12770612 [TBL] [Abstract][Full Text] [Related]
20. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Takeshita S; Pu LQ; Stein LA; Sniderman AD; Bunting S; Ferrara N; Isner JM; Symes JF Circulation; 1994 Nov; 90(5 Pt 2):II228-34. PubMed ID: 7525111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]